Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (671-680 of 716) with videos related to

Pageof 72
Sort By:
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responsesCharles H Redfern, Troy H Guthrie, Alberto Bessudo, et al.
Diabetologia|February 22, 2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesPedro Cardoso, Katie G Young, Anand T N Nair, et al.
Diabetes Care|October 30, 2021
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision MedicineAbhinav Sharma, Yinggan Zheng, Justin A Ezekowitz, et al.
Circulation. Cardiovascular Imaging|January 7, 2011
Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic functionJan van Ramshorst, M Louisa Antoni, Saskia L M A Beeres, et al.
Annals of Neurology|October 9, 2018
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E<sub>2</sub> to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in miceSaravanan S Karuppagounder, Lauren Alin, Yingxin Chen, et al.
Circulation|April 18, 2023
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION TrialMoritz J Hundertmark, Amanda Adler, Charalambos Antoniades, et al.
Diabetes Care|May 23, 2018
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysisLee Ling Lim, Eric S H Lau, Alice P S Kong, et al.
JCI Insight|August 8, 2023
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetesJessica A Regan, Robert J Mentz, Maggie Nguyen, et al.
JAMA Cardiology|July 21, 2016
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical TrialDarren K McGuire, Frans Van de Werf, Paul W Armstrong, et al.
Pageof 72

Showing results (671-680 of 716) with videos related to

Sort By:
Pageof 72
Health Technology Assessment (Winchester, England)|April 14, 2018
Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCTSimon J Griffin, M Angelyn Bethel, Rury R Holman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responsesCharles H Redfern, Troy H Guthrie, Alberto Bessudo, et al.
Diabetologia|February 22, 2024
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetesPedro Cardoso, Katie G Young, Anand T N Nair, et al.
Diabetes Care|October 30, 2021
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision MedicineAbhinav Sharma, Yinggan Zheng, Justin A Ezekowitz, et al.
Circulation. Cardiovascular Imaging|January 7, 2011
Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic functionJan van Ramshorst, M Louisa Antoni, Saskia L M A Beeres, et al.
Annals of Neurology|October 9, 2018
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E<sub>2</sub> to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in miceSaravanan S Karuppagounder, Lauren Alin, Yingxin Chen, et al.
Circulation|April 18, 2023
Assessment of Cardiac Energy Metabolism, Function, and Physiology in Patients With Heart Failure Taking Empagliflozin: The Randomized, Controlled EMPA-VISION TrialMoritz J Hundertmark, Amanda Adler, Charalambos Antoniades, et al.
Diabetes Care|May 23, 2018
Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysisLee Ling Lim, Eric S H Lau, Alice P S Kong, et al.
JCI Insight|August 8, 2023
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetesJessica A Regan, Robert J Mentz, Maggie Nguyen, et al.
JAMA Cardiology|July 21, 2016
Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical TrialDarren K McGuire, Frans Van de Werf, Paul W Armstrong, et al.
Pageof 72